  |
 | Up a level |
Miles, David and Cameron, David and Bondarenko, Igor and Manzyuk, Lyudmila and Alcedo, Juan Carlos and Lopez, Roberto Ivan and Im, Seock-Ah and Canon, Jean-Luc and Shparyk, Yaroslav and Yardley, Denise A and Masuda, Norikazu and Ro, Jungsil and Denduluri, Neelima and Hubeaux, Stanislas and Quah, Cheng and Bais, Carlos and O'Shaughnessy, Joyce (2017) Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. European journal of cancer, 70. pp. 146-155. ISSN 1879-0852
Li, Weimin and O'Shaughnessy, Joyce and Hayes, Daniel and Campone, Mario and Bondarenko, Igor and Zbarskaya, Irina and Brain, Etienne and Stenina, Marina and Ivanova, Olga and Graas, Marie-Pascale and Neven, Patrick and Ricci, Deborah and Griffin, Thomas and Kheoh, Thian and Yu, Margaret and Gormley, Michael and Martin, Jason and Michael, Schaffer and Zelinsky, Kathy and De Porre, Peter and Johnston, Stephen R.D. (2016) Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research, 22 (24). pp. 6002-6009. ISSN 1078-0432 (print), 1557-3265 ( online)
